CLINICAL TRIALS PROFILE FOR MOVIPREP
✉ Email this page to a colleague
All Clinical Trials for Moviprep
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00312481 ↗ | MOVIPREP® Versus PICOLAX® Pilot Study | Completed | Norgine | Phase 2 | 2005-07-01 | This will be a randomised, single-centre, single-blind, parallel-group, pilot study in patients undergoing colonoscopy. The primary objective is to evaluate the efficacy of MOVIPREP® versus PICOLAX® for gut cleansing prior to colonoscopy. The secondary objectives are to evaluate the safety, tolerability and acceptability of MOVIPREP versus PICOLAX for gut cleansing prior to colonoscopy. |
| NCT00322062 ↗ | MOVIPREP® Versus NaP Pivotal Phase III Study | Completed | Norgine | Phase 3 | 2002-04-01 | The aim of the study is to compare a new 2 litre bowel cleansing product versus a sodium phosphate solution already on the market. Efficacy of each bowel preparation, safety and acceptability will be assessed. |
| NCT00389233 ↗ | A Phase III Trial to Assess the Efficacy, Acceptability and Safety of Moviprep® Versus a 4L PEG+E Standard Solution | Completed | Norgine | Phase 3 | 2002-06-01 | The study was carried out as a randomised, single-blind, active-controlled, multi-centric, phase III study with two parallel treatment groups. The primary efficacy criterion was the frequency of effective gut cleansing in each of the two treatment groups (grade A or B "overall quality of gut cleansing" as judged by a blinded expert panel on the basis of videotapes recorded during the endoscopic procedure). |
| NCT00427089 ↗ | Comparison of 2L NRL994 With NaP Preparation in Colon Cleansing Prior to Colonoscopies for Colon Tumor Screening | Completed | Norgine | Phase 3 | 2004-09-01 | To compare the efficacy, acceptability and safety of the new 2 liter gut cleansing solution (Moviprep) and NaP preparation in routine colon cleansing prior to tumor screening colonoscopies |
| NCT00605228 ↗ | A Phase IV Study, of the Efficacy, Safety, and Acceptability of Moviprep® Versus Colopeg® in Colonoscopy Preparation | Completed | International Clinical Trials Association | Phase 4 | 2007-05-01 | Primary: - To demonstrate the superiority of Moviprep® versus Colopeg® in gut cleansing prior to colonoscopy. Secondary: - To assess the safety of Moviprep® versus Colopeg®. - To assess acceptability of Moviprep® versus Colopeg®. |
| NCT00605228 ↗ | A Phase IV Study, of the Efficacy, Safety, and Acceptability of Moviprep® Versus Colopeg® in Colonoscopy Preparation | Completed | Norgine | Phase 4 | 2007-05-01 | Primary: - To demonstrate the superiority of Moviprep® versus Colopeg® in gut cleansing prior to colonoscopy. Secondary: - To assess the safety of Moviprep® versus Colopeg®. - To assess acceptability of Moviprep® versus Colopeg®. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Moviprep
Condition Name
Clinical Trial Locations for Moviprep
Trials by Country
Clinical Trial Progress for Moviprep
Clinical Trial Phase
Clinical Trial Sponsors for Moviprep
Sponsor Name
